Aspire Financial Statements From 2010 to 2025

ASBP Stock   0.09  0  2.16%   
Analyzing historical trends in various income statement and balance sheet accounts from Aspire BioPharma,'s financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Aspire BioPharma,'s valuation are summarized below:
Gross Profit
884
Market Capitalization
13.4 M
Enterprise Value Revenue
10.4 K
Revenue
1.9 K
Earnings Share
(0.64)
Aspire BioPharma, does not presently have any fundamental signals for analysis.
Check Aspire BioPharma, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aspire BioPharma,'s main balance sheet or income statement drivers, such as Tax Provision of 443, Interest Expense of 936.2 K or Selling General Administrative of 573.1 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Aspire financial statements analysis is a perfect complement when working with Aspire BioPharma, Valuation or Volatility modules.
Check out the analysis of Aspire BioPharma, Correlation against competitors.
To learn how to invest in Aspire Stock, please use our How to Invest in Aspire BioPharma, guide.

Aspire BioPharma, Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets140.6 K148 K243.9 M
Slightly volatile
Short and Long Term Debt Total1.3 M1.3 M207.6 K
Slightly volatile
Other Current Liabilities110.7 K111 K260.3 K
Slightly volatile
Total Current Liabilities926 K1.7 M443.2 K
Slightly volatile
Accounts Payable222.1 K310.2 K143.8 K
Slightly volatile
Cash3.5 K3.6 K405.2 K
Slightly volatile
Cash And Short Term Investments3.5 K3.6 K405.2 K
Slightly volatile
Common Stock Shares Outstanding51.2 M47.6 M46.4 M
Slightly volatile
Liabilities And Stockholders Equity140.6 K148 K243.9 M
Slightly volatile
Other Current Assets198.2 K107.9 K509.2 K
Slightly volatile
Other Stockholder Equity1.1 M1.2 M818.8 K
Slightly volatile
Total Liabilities1.6 M1.7 M9.3 M
Slightly volatile
Short and Long Term Debt1.3 M1.3 M207.6 K
Slightly volatile
Total Current Assets140.6 K148 K912.8 K
Slightly volatile
Capital Stock20.9 K22 K196.5 K
Slightly volatile
Non Current Liabilities Other3.1 M3.5 M3.8 M
Slightly volatile
Short Term Debt1.3 M1.3 M207.6 K
Slightly volatile
Common Stock18.8 K19.8 K242.9 M
Slightly volatile
Net Receivables29.2 K32.9 K35.8 K
Slightly volatile

Aspire BioPharma, Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision443433593
Slightly volatile
Selling General Administrative573.1 K940.4 K415.3 K
Slightly volatile
Selling And Marketing Expenses77.4 K126.1 K52.2 K
Slightly volatile
Other Operating Expenses3.2 M3.1 M902.8 K
Slightly volatile
Research Development104.5 K144.4 K162.5 K
Slightly volatile
Total Operating Expenses3.2 M3.1 M902.8 K
Slightly volatile
Income Tax Expense777K650
Slightly volatile
Interest Income521.2 K548.7 K5.2 M
Slightly volatile

Aspire BioPharma, Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Change In Working Capital797.6 KM526.5 K
Slightly volatile
Begin Period Cash Flow10.6 K11.2 K183.2 K
Very volatile
End Period Cash Flow5.4 K3.6 K1.3 K
Slightly volatile
Other Cashflows From Investing Activities227.9 M256.4 M279.6 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables118.2 K133 K145 K
Slightly volatile
ROIC11.8711.30416.4368
Slightly volatile
Cash Per Share5.0E-44.0E-41.0E-4
Slightly volatile
ROE8.558.14084.8562
Pretty Stable
Intangibles To Total Assets179124202
Slightly volatile
Current Ratio0.120.08770.1394
Slightly volatile
Capex Per Share0.00180.00190.0869
Slightly volatile
Average Receivables14.6 K16.4 K17.9 K
Slightly volatile
Interest Debt Per Share0.270.26180.0342
Slightly volatile
Debt To Assets4.78.56032.3251
Slightly volatile
Ebt Per Ebit3.253.653.983
Slightly volatile
Return On Capital Employed2.712.00554.1038
Slightly volatile
Quick Ratio0.120.08770.1394
Slightly volatile
Net Income Per E B T0.80.90.9822
Slightly volatile
Cash Ratio0.0020.00220.0018
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.140.1528.6702
Slightly volatile
Debt Ratio4.78.56032.3251
Slightly volatile
Return On Equity8.558.14084.8562
Pretty Stable

Aspire BioPharma, Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap75.9 M85.4 M93.1 M
Slightly volatile
Enterprise Value76.9 M86.5 M94.4 M
Slightly volatile

Aspire Fundamental Market Drivers

About Aspire BioPharma, Financial Statements

Aspire BioPharma, shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Aspire BioPharma, investors may analyze each financial statement separately, they are all interrelated. The changes in Aspire BioPharma,'s assets and liabilities, for example, are also reflected in the revenues and expenses on on Aspire BioPharma,'s income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year

Pair Trading with Aspire BioPharma,

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aspire BioPharma, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aspire BioPharma, will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aspire Stock

  0.74NVO Novo Nordisk AS Buyout TrendPairCorr

Moving against Aspire Stock

  0.89MTC MMTEC Inc Tech BoostPairCorr
  0.86MRK Merck Company Aggressive PushPairCorr
  0.85JNJ Johnson JohnsonPairCorr
  0.83GSK GlaxoSmithKline PLC ADRPairCorr
  0.82AZN AstraZeneca PLC ADRPairCorr
The ability to find closely correlated positions to Aspire BioPharma, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aspire BioPharma, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aspire BioPharma, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aspire BioPharma, to buy it.
The correlation of Aspire BioPharma, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aspire BioPharma, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aspire BioPharma, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aspire BioPharma, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Aspire Stock Analysis

When running Aspire BioPharma,'s price analysis, check to measure Aspire BioPharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspire BioPharma, is operating at the current time. Most of Aspire BioPharma,'s value examination focuses on studying past and present price action to predict the probability of Aspire BioPharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspire BioPharma,'s price. Additionally, you may evaluate how the addition of Aspire BioPharma, to your portfolios can decrease your overall portfolio volatility.